PubMed · 1526066
Xanthines inhibit human platelet aggregation induced by platelet-activating factor.
Abstract
1. Platelet-activating factor (PAF) may be involved in the pathogenesis of asthma, and therefore the effects of the anti-asthma drugs theophylline and enprofylline on human platelet aggregation and adenosine triphosphate (ATP) release induced by PAF and adenosine diphosphate (ADP) were studied. 2. Enprofylline (50% inhibitory concentration [IC50] = 94.8 +/- 13.2 mumol/L) was more potent than theophylline (IC50 = 934.1 +/- 40.1 mumol/L) as an inhibitor of PAF-induced aggregation, and the xanthines were twice as potent as inhibitors of PAF-induced aggregation when compared with ADP-induced aggregation. ATP release was 1.4 times more sensitive to inhibition by the xanthines than aggregation. 3. Although high concentrations of xanthines inhibited platelet aggregation and ATP release induced by PAF, therapeutic concentrations are unlikely to inhibit PAF-induced effects.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
N L Misso, P J Thompson. 1992. Xanthines inhibit human platelet aggregation induced by platelet-activating factor.. https://doi.org/10.1111/j.1440-1681.1992.tb00510.x
Cite the original work for its findings. Save a collection to share your selection of sources.